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Background: Pediatric oral hemangiomas are benign vascular tumors that can be seen from birth, particularly in 
females. Hemangiomas are most frequent located in the lips and usually regress spontaneously, thus they do not 
require any type of treatment in most cases. The present scoping review pretended to synthesize the most relevant 
and currently available information from the international dental literature published in the last 25 years, regard-
ing the management of pediatric oral hemangiomas.
Material and Methods: An exhaustive literature search was performed in four electronic databases (PubMed, Em-
base, Google Scholar, and Cochrane). Initially, 241 related titles and abstracts were found. After the duplication 
removal, screening, and assessment processes, 37 records were included for full-text reading. Finally, 20 articles 
in the English language were included in the scoping review for data extraction and assessment.
Results: We identified and subsequently discussed three fundamental issues associated to the management of 
pediatric oral hemangiomas: (i) clinical characteristics, differential diagnosis, and histopathological findings; (ii) 
evolution and complications; and (iii) current available treatment modalities.
Conclusions: Although these like-tumor lesions are uncommon, pediatric dentistry practitioners must be familiar 
with the inherent clinical characteristics, diagnosis approaches, and currently available treatment options. Now-
adays, surgical removal and non-invasive medical/pharmacologic therapies are the best management modalities 
for pediatric oral hemangiomas.
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Introduction
According to the American Academy of Pediatric Den-
tistry (AAPD), there has been described numerous le-
sions, masses, or tumor-like conditions of soft and hard 
tissues, belonging to the oral and maxillofacial regions 
of children and adolescents; the majority of these lesions 
are mucosal conditions (1). Intra-oral mucosal lesions in 
American children between 2 and 17 years old have an 
incidence greater than 9%, being the vascular tumors 
the most common benign lesions (2). Oral vascular 
tumors encompass a wide spectrum of congenital and 
neonatal anomalies whose predominant components are 
vascular structures (3). The single term hemangioma 
(HEM) has been used in the medical/dental literature to 
describe the localized benign vascular tumor of infancy/
childhood of mesenchymal origin (4,5). However, this 
term has been also employed for a wide range of muco-
sal/skin vascular pathologies, including “strawberry”, 
“port-wine”, and “salmon patch” (3,6). This varied ter-
minology has led to confusion among clinicians in the 
diagnosis and treatment of these tumors (7). Likewise, 
it has extensively discussed if hemangiomas should be 
considered as neoplasms, hamartomas, or vascular mal-
formations (4).
The vascular lesions of childhood are classified into two 
categories: hemangiomas (proliferating or involuting) 
and vascular malformations (8). Later, this classifica-
tion was modified by the International Society for the 
Study of Vascular Anomalies in 1996 (9,10), in which 
vascular lesions were subdivided into (i) tumors (infan-
tile and congenital hemangioma, pyogenic granuloma, 
and other rare entities) and (ii) vascular malformations.
HEM is the most common benign tumor of the blood 
vessels in infants and children; 80% of these tumors are 
present as isolated entities (11). This lesion is found oc-
casionally in the mouth -along with lymphangiomas ac-
count for up to 30% of oral cavity tumors in the pediat-
ric population- (2). It is observed more frequently in the 
lips, oral mucosa, cheek, tongue, palatal mucosa, sali-
vary glands, and mandibular bone; and in the skin of the 
head, face, and neck (12). It has an incidence between 
3% and 10% by the age of one year (13). The condition 
is more common in premature low-birth-weight infants 
(< than 1000 g), decreasing gestational age, in white fe-
male children, and in twins (9); other related risk factors 
are multiple gestation pregnancy, gestational hyperten-
sion, placenta previa, preeclampsia, chronic villus sam-
pling, and antenatal vaginal bleeding (4,14). It occurs 
usually during the neonatal period (6,15). The tumor ex-
hibits rapid growth and expansion with endothelial cell 
proliferation during the first five or six months of life, 
followed by a gradual self-involution to near-complete 
resolution (4); approximately 50-80% of all HEM disap-
pear by 5 years of age (2). When needed, treatment can 
be surgical and/or pharmacological (16).
The aim of the present scoping literature review is 
to explore, describe, and discuss the most current 
evidence about the management of HEMs in the oral 
cavity of infants and children.
Material and Methods
For the present scoping review, we judiciously fol-
lowed the guidelines of Preferred Reporting Items 
for Systematic Reviews or Meta-Analyses Extension 
for Scoping Reviews (PRISMA-ScR) (17), and the 
recommendations of Arksey and O’Malley (18), and 
Levac et al. (19) methodologies. The next practice-
orientated research question was structured: What is 
the best current evidence about the management of 
oral hemangiomas in infants and children?
A comprehensive literature search was carried be-
tween January to May 2019, using four electronic da-
tabases: PubMed, Embase, Google Scholar, and the 
Cochrane Library. The included articles were limited 
to English and Spanish languages only, published 
during the last 25 years, with the following method-
ological designs: narrative/systematic reviews ran-
domized clinical controlled trials (RCCTs), cohort 
and case and control studies, and clinical case re-
ports; focused on clinical/histological characteristic, 
diagnosis and the different treatment modalities, and 
other useful information about oral and peri-oral lo-
calized hemangiomas in infants and children (since 
birth up to 12 years old). Guest editorials, clinical 
opinions, abstracts, gray literature, conference re-
views, and meeting highlights were excluded. The 
principal keywords and MeSH terms employed, alone 
or in combination with Boolean operators, for the dif-
ferent searches were as follows: “oral vascular tumors 
OR lesions”, “oral hemangioma”, “infantile hemangi-
oma”, “congenital hemangioma”, AND “children OR 
pediatric patients”. This search strategy was adapted 
for use in every database.
Related titles and abstracts were identified and as-
sessed by two pre-calibrated independent authors 
(ABP and OBC) for eligibility, after eliminating du-
plicated articles. The studies that appeared to meet 
the inclusion criteria were retrieved in their full-text 
version and evaluated. A manual search for additional 
relevant titles was also carried out in the bibliograph-
ic reference list reported by each included article. Af-
ter that, useful data (first author’s name, publication 
year, country, research design, sample size (in cases 
of RCCTs, cohort, or case-control studies), and au-
thor’s main reported outcomes, findings, and recom-
mendations) were extracted from each study, using a 
pre-piloted specific form; this collected information 
was then synthesized and thematically organized in 
a special chart. These tasks were performed by the 
other two authors (APG and AGR) who were also pre-
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viously calibrated. We did not any kind of quality ap-
praise of included articles. Any discrepancy occurred 
during these two stages was resolved by discussion 
and consensus with a third author (MMB).
Results
In this review, the authors initially found 241 ref-
erences. However, after the processes of duplica-
tion removal, screening and exclusion, 37 records 
were included for data extraction and full-text as-
sessment. Finally, we selected 20 English language 
references, which met the inclusion criteria and 
considered as relevant and most representative for 
the presented clinical topic. Fig. 1 summarizes the 
screening and selection processes as a PRISMA 
f lowchart. The selected studies were published from 
1999 to 2019.
The included articles were from 13 countries, span-
ning North America, Central and Eastern Asia, Eu-
rope, and North Africa. In terms of health science 
discipline, most studies were identified as pediatric 
dentistry, oral medicine/pathology, and maxillofacial 
surgery-oriented; six articles were multidisciplinary. 
Regarding the methodological design, most stud-
ies were retrospective cohorts with chart reviews, 
case reports, and narrative reviews. No RCCTs were 
found. General information and characteristics of the 
included articles are described in Table 1 (4-6,10-
16,20-29). After the analysis of the included articles, 
we identified three fundamental themes associated 
to the management of pediatric oral hemangiomas: 
(i) clinical characteristics, differential diagnosis, and 
histopathological findings; (ii) evolution and compli-
cations; and (iii) current available treatment modali-
ties. These issues will be extensively discussed in the 
next section.
Fig. 1: PRISMA flow diagram of literature search.
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sign Patient characteristics and main reported findings/results





•	 105 medical record from  patients under 15 yrs
•	 25 HEM detected
•	 14 of them localized in one of the lips
•	 Most common age: 12-15 yrs
•	 Treated with surgical resection
•	 Only 2 lesions exhibited recurrence




•	 Four patients with lip vascular lesions (only one diagnosed with HEM)
•	 HEM of the upper lip with extensive muscular involvement in a 4-month-old girl. Treated 
with oral corticoids and surgical removal





•	 31 infants (aged 1-60 months) with facial and cervical HEM 
•	 23 girls, 8 boys
•	 6 HEM located in the cheek
•	 6 in the upper lip
•	 2 in the lower lip
•	 All lesions were early operated
•	 Most treated patients exhibited good or very good results
•	 Early removal (before school-age) is justified because of the social and psychological 
impact for the patient and family 






•	 Three patients (1 infant) treated only with 5% ethanolamine olate (EO)
•	 A ten-week-old girl 
•	 The HEM was located in the upper lip
•	 Episodes of spontaneous bleeding and breast feeding difficulties
•	 The HEM was treated with intra-lesional injections of the sclerosing agent, under local anesthesia
•	 The total amount of injected EO was 4 cc in three successive appointments, two weeks apart 
Kutluhan et al. 
(24), Turkey Case report
•	 A seven-year-old girl with a tongue HEM
•	 Associated bleeding and pain
•	 4x2 cm in size
•	 Treated with plasma knife surgery under general anesthesia
•	 The complete healing occurred in three weeks





•	 An eight-year-old girl with a giant cavernous HEM involving the lower lip
•	 Associated to evident mandibular deformation with absorption of the lateral cortical plate 
of the mandibular body
•	 Also with permanent open mouth, saliva drooling, and severe speech difficulties
•	 15x12x6 cm in size
•	 The lesion was surgically treated
Bonet-Coloma 






•	 26 medical record of children aged 0-14 yrs with oral HEM 
•	 19 girls and 9 boys
•	 9 congenital HEM
•	 23 HEM located in one of the lips
•	 Lesion mean diameter: 1.67 cm
•	 The treatment options were surgical extirpation (13 cases) and embolization (2 cases)
•	 13 disappeared spontaneously and there were no recurrences







•	 56 pediatric patients with parotid HEM 
•	 39 girls and 17 boys
•	 38 focalized and 18 segmental HEM
•	 Mean age of presentation: 5.1 weeks
•	 Associated with skin ulcerations, facial deformities, airway and/or auditive canal obstruc-
tion, and other organ involvement
•	 Treatment options: systemic steroid therapy, surgical excision, oral propranolol, and endo-
vascular sclerotherapy
•	 Seven lesions involuted spontaneously  







•	 11 pediatric patients with lip HEM for surgical correction 
•	 Ten girls
•	 Seven lesions were present in the lower lip
•	 Mean age: 3.6 yrs
•	 The surgical outcomes were rated as between good and good-to-excellent
•	 Treatment goals include the restoration of normal lip contour and color, and strategic 
placement of the incision
Table 1: Relevant extracted characteristics and main findings from included studies.
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•	 A 7 years old boy with a submandibular salivary gland swelling 
•	 Diagnosed as cavernous HEM with multiple phlebolitis and thrombophlebitis
•	 No pain neither salivary flow difficulties, and normal feeding
•	 The lesion was surgically removed  








•	 IH show great heterogeneity in size, morphology, growth residual remaining after involu-
tion, and degree of response to treatment
•	 Lip and perioral IHEM are associated to ulcerations, facial deformities, and feeding dif-
ficulties
•	 Propanolol is currently the first therapy option for these lesions for infants and children 




•	 A 4-year-old girl exhibiting a painless pedunculated IHEM in the palate (3x3x2 cm in 
diameter)
•	 Normal speech was compromised
•	 The lesion was differentiated from pyogenica granuloma and squamous papilloma
•	 The lesion was surgically extirpated. However, a new similar but smaller and asymptom-
atic HEM appeared 8 months later; this was placed under observation 







•	 Histologically, oral HME are classified into two types: capillary and cavernous
•	 HEM result form an aberrant focal proliferation of endothelial cells, although the cause 
behind this event is still unknown  










•	 Oral HEM are frequently incorrectly diagnosed
•	 Head and neck HEM represent the 40% to 60% of all cases in children
•	 It has been proposed that HEM are originated by autosomal transmission
•	 Current HEM treatment modalities: surgical removal, corticoid therapy, interferon injec-
tions, antiadrenergic agents, and laser treatment 








•	 IHEM is the most common tumor of the head and neck of children, affecting around 3-5% 
of children
•	 Color Doppler ultrasound imaging is an useful diagnostic tool to visualize and differenti-
ate IHEM from other vascular tumors
•	 Congenital HEM account for only 3% of all HEM. It is distinct from IHEM in that they 
are already mature at birth and do not proliferate
Léauté-Labrèze 






•	 About 10-15% of IHEM cause complications, including obstructions, functional impair-
ment, ulcerations, and facial disfigurements
•	 Subcutaneous IHEM in the parotid region tend to persist longer than other peri-oral HEM
Chan et al. (12), 
USA Case report
•	 A 8-year-old male
•	 A capillary HEM located in the mandibular body, angle, and ramus
•	 The tumor was treated with embolization and surgical resection, without complications 








•	 60% of the diagnosed vascular lesions are located in the head, face and neck region, af-
fecting about 1 in 22 children
•	 Intralesional sclerotherapy (e.g. 3% sodium tetra-decylsulphate) is currently the mainstay 
of  HEM treatment; the usual interval between the injections of the sclerosing agent is 
every 2 to 4 weeks




•	 77 pediatric patients 
•	 61 girls and 16 boys
•	 29 oral or perioral HEM  
•	 Treated for HEM with removal surgery, oral corticosteroids, or oral beta-blockers










•	 Ultrasound is the modality of choice for pediatric HEM diagnosis, to assess both the ex-
tension of the lesion and the degree of vascularity
•	 Due to the associated ionizing radiation, computed tomography is restricted only to bone 
involvement of the HEM
•	 Magnetic resonance imaging is used for differential diagnosis especially in deep tissues 
that cannot be diagnosed clinically; however, it requires general anesthesia in cases of 
small children 
Table 1 cont.: Relevant extracted characteristics and main findings from included studies.
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Discussion
According to the American Academy and Pediatric 
Dentistry, the management of oral cavity tumor-like 
conditions in children is determined by diverse ana-
tomical and physiological differences from those of 
adult patients (1). First, pediatric oral tumors usually 
grow faster and are less predictable in behavior; in the 
second place, although the same physiological factors 
that affect lesion growth are present, these can play a 
more favorable role in healing after surgical remov-
al; finally, children are more resilient and heal more 
quickly than adults.
As above mentioned, the present scoping review de-
termined three principal issues about the pediatric 
oral hemangiomas to be approached and discussed: (i) 
clinical characteristics, differential diagnosis, and his-
topathological findings; (ii) evolution and complica-
tions; and (iii) current available treatment modalities.
i. Clinical characteristics, differential diagnosis, and 
histopathological findings.
Diagnosis of HEM is based on a comprehensive histo-
ry and clinical examination of the lesion. Only a lesion 
monitoring or conservative management is suggest-
ed for this tumor due to its propensity for spontane-
ous regression in children (2). Pediatric dentists and 
maxillofacial surgeons participate, as part of a mul-
tidisciplinary health care team, in the diagnosis and 
treatment of affected children, especially if the tumor 
endangers the dentition development or when bone 
tissue is involved (2,10). Therefore, it is mandatory a 
precise diagnosis –through clinical and imaging as-
sessment– of the type of oral vascular lesion or tumor 
because it may considerably influence the treatment 
planning (12). Regardless of the pediatric patient’s 
age, it is imperative to institute an accurate working 
diagnosis for each individual oral lesion detected, in 
order to differentiate between developmental anoma-
lies, reactive or inflammatory lesions, and neoplastic 
tumors; in this regard, intra-oral soft tissue swellings 
are frequently overlooked and determined as inflam-
matory lesions (27). On the other hand, it has been 
reported that children with neurofibromatosis type 1 
(or Von Recklinghausen’s disease) are susceptible to a 
variety of benign tumors, including face and oral skin 
HEM (30,31).
HEM may be located superficially or deeply (21,23). 
Most superficial oral mucosal lesions are manifested 
as a well-circumscribed, firm, isolated, and raised dark 
red lesion (macula, papule, or nodule –depending on the 
congestion degree and deepness into the tissue–) that is 
rubbery on palpation (2,9); some of these clinical fea-
tures can be observed in Fig. 2, which corresponds to 
a female child attending our pediatric dentistry clinic a 
few months ago. For superficial HEM, particularly those 
located in the skin of the parotid gland region, diascopy 
can be employed for diagnostic purposes (32,33).
Fig. 2: Clinical images of a HEM in the right side of the face, involving the lower lip –crossing the vermilion-skin junction–, and the cheek 
mucosa. The patient, a 5-year-6-month girl, was referred to our pediatric dentistry clinic (Pediatric Dentistry Postgraduate Program; Faculty of 
Dentistry; University of San Luis Potosi, Mexico). According to the parents, the lesion was no present at the birth; it was noted around six months 
earlier and showed rapid growth. On clinical examination, the intraoral bulge felt firm and the overlying skin showed a purple discoloration. The 
patient and parents did not report any history of ulceration or hemorrhage episodes, nor eating, speaking or respiratory problems. Thus, it was 
decided to closely observe the lesion for 6 to 9 months, waiting for a spontaneous involution.
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Vascular lesions tend to blanch in response to the appli-
cation of a firm pressure by a flat transparent instrument 
–for example, a glass slide–, during 1 or 2 minutes. 
When the instrument is removed, the lesion remains 
pale for a few seconds; then, it slowly starts refilling 
again from the feeder vessels. According to Tanwar et 
al. (33), diascopy can determine whether the color of a 
lesion is due to blood present in the vessels (as in HEM) 
or to extravasated blood present in the tissues: the for-
mer case will blanch on pressure and the later will not. 
However, in problematic identification cases, diagnosis 
of HEM should be confirmed through imaging methods 
such as Doppler ultrasound, magnetic resonance imag-
ing, or angiography (13,25).
When HEMs are in the deeper dermis, they are mani-
fested as a slight discoloration of the overlying skin (21). 
HEM, particularly the capillary type, should be differ-
entiated from other vascular tumors, particularly from 
the pyogenic granuloma (PG; also called lobular cap-
illary hemangioma). Histopathologically, both lesions 
resemble each other however PG is usually much small-
er and more reactive in nature than HEM, it appears 
mostly in the gingiva, after the first year of life, and 
has a typical history of a non-healing/bleeding wound 
(23,34); furthermore, unlike HEM, PG is predominant-
ly an epithelial rather than an endothelial lesion, and 
exhibits immunocytochemical and ultrastructural dif-
ferences in relation to HEM.
Although HEM and arteriovenous malformations 
(AVM) are considered clinically similar, both lesions 
exhibit some different histochemical and microscopic 
characteristics, which can help establish a definitive 
diagnosis. AVMs are the result of errors in morpho-
genesis of arteries and venous, while HEMs are a 
consequence of a derangement in angiogenesis with 
proliferation of vascular elements. In their anatomic 
pathology study, Adegboyega and Suimin mentioned 
that the presence of arteries, arterioles, and intral-
esional nerves is characteristic of AVM, but not ob-
served in HEM. Additionally, the endothelial lining 
of HEM is plump, and when cultured, they proliferate 
and form tubular structures like vascular channels; on 
the other hand, the endothelial cells lining AVM are 
quiescent flat cells that neither proliferate nor differ-
entiate into vascular structures (35).
Gliomas and other malignant vascular lesions must be 
also considered in the differential diagnosis (23). In this 
same regard, pediatric oral HEMs rarely require imag-
ing for differential diagnosis. However, in some dubious 
or borderline cases imaging is necessary to assess the 
extent and penetration of the lesion, the degree of vas-
cularity, as well as its evolution. Ultrasound and asso-
ciated Doppler spectra are the most employed imaging 
tools for performing these actions, and also for monitor-
ing the treatment effects on the lesion (6). Regarding to 
this, ultrasound can show the highly vascular nature of 
HEM, evidenced by the presence of multiple prominent 
vessels (36); thus, this diagnostic method is very useful 
because it can clearly discriminate if a tumor is cys-
tic (rather vascular or lymphatic malformation) or solid 
(rather HEM) (6).
Histopathologic/microscopic features.
In the present scoping review, seven articles 
(7,12,26,27,34,37,38) were identified in which a histo-
pathological or microscopic evaluation was performed; 
all of them were clinical cases on pediatric oral HEM, 
particularly the capillary type.  According to different 
authors (4,23,37), HEMs may present a spectrum of 
histopathological findings, consisting in general of hy-
perplastic endothelial cells exhibiting increased mitotic 
activity (13). In their simplest classification, HEMs are 
classified into three types: capillary, cavernous (large-
vessel), and mixed, according to the size of vascular 
spaces. Capillary HEM has numerous small vessels 
(10-100 microns in diameter) supported in a connective 
tissue stroma of varying density. Its vessels have walls 
1-3 cells thick, and tend to run in parallel; there is also 
a single layer of endothelial cells with no shedding and 
no aplasia. Cavernous HEM possesses a similar appear-
ance but the vessel walls are thinner and the lumina are 
larger; its cavernous vessels or sinusoids are lined by 
epithelial cells, separated by a thin layer of connective 
tissue septa. In general, the cavernous HEM is larger 
and more diffuse than the capillary HEM (11). Mixed 
HEMs contain both components and may be more com-
mon than the pure cavernous lesion (37).
Following the AAPD guidelines for HEM cases, the 
provisional diagnosis is carried out through an in-depth 
clinical history, assessing the risk factors and docu-
menting the clinical signs and symptoms of the lesion. 
Then, a list of potential lesions with similar features is 
rank-ordered from most likely to least likely diagnosis. 
The condition that is considered to be the most likely 
one becomes the working diagnosis and determines the 
initial management approach (1). For difficult cases, 
immunohistochemical analysis (e.g. expression of hu-
man glucose transporter one protein or GLUT-1) and 
ultrasound imaging are employed (3,10). GLUT-1 is an 
immunological marker expressed by HEM’s endothelial 
cells frequently employed in tissue biopsies to differ-
entiate vascular tumors from malformations; a posi-
tive stain for GLUT-1 excludes vascular malformations 
and is suggestive of HEM. This tool is considered as 
a helpful additional indicator for diagnosing HEM (3). 
However, this positive result is also possible for other 
vascular lesions, including epitheloid hemangioendo-
theliomas, angiosarcomas, and angiokeratomas; so, the 
final diagnosis for HEM should be made through the 
interpretation of all clinical and diagnostic features, and 
not based on GLUT-1 staining alone (6,39).
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ii. Evolution and complications.
As previously stated, it has been suggested that HEMs 
have three different development stages: proliferative, 
involuting, and involuted. The proliferative phase is 
characterized by rapid endothelial cell divisions, dis-
playing a tenfold increase in mast cell concentration 
over the lesions and the normal tissue. During the in-
voluting phase, endothelial cell activity decreases and 
cellular parenchyma is substituted by fibrofatty tissue 
(23). Recently, diverse biological positive and negative 
regulators of angiogenesis have been identified for ev-
ery HEM biological evolutional phase (e.g. CD31, the 
von Willebrand factor, the basic fibroblast growth factor 
or BFGF, the proliferating cell nuclear antigen, and the 
vascular endothelial growth factor or VEGF); it is be-
lieved that the imbalance of these regulators influences 
the lesion’s pattern of growth (23,25,40).
Oral HEMs may be associated with other craniofacial 
conditions, such as anterior open bite, salivary leak-
age, or diverse facial unacceptable deformations, as 
well as chewing and speaking disabilities (24). As a 
consequence, these anomalies can origin strong psy-
chological impacts and inadequate social integration 
of the affected child. Weiss et al. (25) mention that the 
treatment of parotid hemangiomas is really challenging 
due to their profuse growth, which may cause signifi-
cant shunting; in turn, this shunting may result in con-
gestive cardiac failure. According to Püttgen el at. (14), 
ulcerations are also a common complication, occurring 
in up to 25% of pediatric patients at referral centers. 
Other mentioned complication is the auditory canal ob-
struction in cases of parotid gland HEMs (25). On the 
other hand, although most HEMs are benign processes, 
a small group of them represents serious or potential 
malignant neoplastic conditions (14).
In cases of persisting HEM during the adulthood life, 
the dentist’s clinical behavior should be focused on the 
possible close proximity of the lesion to teeth, periodon-
tal bone, and oral mucosa. According to Elias et al. (10), 
dental extractions and incisional biopsies are prone to 
significant hemorrhages; therefore, the practitioner 
must be aware and prepared to deal with this adverse 
reaction or to refer the affected patient to another oral 
health specialist for more proper management and bet-
ter prognosis.
iii. Currently available treatment modalities.
A total of nine experimental and observational/longitu-
dinal studies were detected in this scoping review deal-
ing with the treatment (surgical or pharmacological) 
and follow-up of oral and maxillofacial hemangiomas 
in pediatric patients (14,15,22,23,25,40-43). Although it 
has been reported that around 50% of HEMs regress 
spontaneously with no permanent damages -thus no 
treatment is required-, it is plenty justified a close obser-
vation of all the lesions (22). Surgical and conservative 
non-surgical treatment options, alone or combined, are 
reserved only in cases of severe ulcerations or infec-
tions, pain, uncontrolled bleeding, airway obstruction, 
or significant cosmetic deformities (16). For example, 
non-surgical interventions have the main objective of 
limiting the cell proliferation, limiting thus the lesion 
size and its distortive effect, and minimizing the risk of 
ulceration (15). One of the medical treatments applied 
nowadays for oral HEMs in children is the corticoid 
therapy (e.g. systemically or through intralesional injec-
tions). Injected corticosteroids are widely used mainly 
for inducing an early involution for large and rapidly 
growing HEMs, especially during the first months of 
life. However, Mcheik et al. (22) and Weiss et al. (25) do 
not encourage this therapy because they have frequently 
observed the appearance of ulceration of the lesion af-
ter the corticoid injection. The systemic administration 
of prednisone or prednisolone has been associated to 
common and severe side effects, such as weight/height 
growth retardation, personality alterations, gastric irri-
tation, and opportunistic infections; also it is frequent 
the lesion rebound growth after cessation of therapy 
(25). Other non-surgical therapies that have been advo-
cated are the endovascular sclerosing agents, such as 5% 
ethanolamine oleate, for the relief of HEM symptoms or 
as a good preparation for further surgery (23,44); the 
interferon alfa-2a, indicated for the treatment of life-
threatening or corticoid-resistant HEM, however irre-
versible spastic diplegia has been reported with its use; 
and laser applications, which have been successfully 
employed for both superficial and deep HEMs (22,45). 
More recently, bleomycin, beta-adrenergic blockers, 
polidocanol, and oral propranolol have been introduced, 
with results so far very promising in terms of therapeu-
tic efficacy and safety in children (25,29,40,42,43). Em-
bolization, cryotherapy, radiations, and chemotherapy 
(e.g. vincristine) have been also tested (24).
Another treatment strategy of choice for HEMs is sur-
gical excision. Lesions located in the lower lip, upper 
lip (involving the vermilion-border and sometimes the 
nose tip), and the parotid/ear region are notoriously 
slow to disappear and commonly need early surgical 
removal. Additionally, the early surgical intervention is 
indicated if the HEM appearance has not changed after 
two years or when the tumor has not responded to non-
surgical therapies. Surgery is also necessary for remov-
ing residual fibrofatty tissue and contour defects after 
the natural involution of HEMs (13,15).
The management of oral hemangiomas does not always 
fall within the scope of the pediatric dentistry field. 
Approximately 12% of pediatric oral HEMs are com-
plex and must be referred to other dental specialties for 
evaluation and management (14). However, many oral 
medicine/pathology specialists often lack capability 
and experience to adequately treat young children; thus, 
it is essential that pediatric dentist practitioners must be 
part and collaborate, as part of a multidisciplinary den-
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tal/medical team, with the purpose of ensuring that af-
fected children are opportunely diagnosed and treated, 
contributing thus to increase the patient’s quality of life. 
On the other hand, it has been mentioned that in many 
towns or cities, particularly of developing countries, 
specialized clinics combining pediatric dentistry and 
oral medicine, specific for the management of rare oral 
mucosal and peri-oral lesions in children, are uncom-
mon or only available in select institutions (46).
In summary, and according with the retrieved infor-
mation, the administration of pharmacological agents 
(orally or using endovascular techniques with low doses 
of propranolol or polidocanol), alone or in combination 
with conservative surgical treatment, are currently the 
standard management approach for HEM and other be-
nign vascular lesions in the oral and maxillofacial areas 
of infants and children; these modalities have demon-
strated to be effective and safe in several well-controlled 
clinical studies with adequate follow-up periods. 
Strengths and weaknesses.
To our knowledge, this scoping review represents one 
of the first attempts to summarize the most current and 
relevant evidence about the management of intraoral 
and peri-oral hemangiomas in the pediatric popula-
tion.  In view of the fact that the volume of published 
information related to this clinical topic is significant, 
we pretend that the present review’s findings contribute 
for a future and more critical and systematic analysis 
of evidence, for the benefit of clinicians and research-
ers. We chose this research design because of the broad 
nature of the clinical topic; this type of review is con-
sidered suitable for stating an overview of the current 
knowledge in a particular health science area, and for 
providing a concise qualitative analysis.
As many scoping reviews, the authors did not perform 
any type of critical appraisal to assess the risk of bias 
of selected articles; thus, some of be included studies 
might be prone to bias and confounding. In this regard, 
we often found noticeable differences among studies 
relative to pediatric hemangiomas in terms of diagnos-
tic criteria and lesion nomenclature. We should recog-
nize that we arbitrarily took methodological some deci-
sions about the organization and analysis processes for 
the final selection the articles, based sometimes on our 
own criteria and experience; for example, we consid-
ered to include only studies that encompassed children 
aged less than 12 years. We are aware of the amount 
of missing potential relevant articles related to the cho-
sen clinical issue approached here; it is possible that 
our search terms or keywords have filtered out impor-
tant studies because they did not appear in the title or 
abstract. Although some of these works could provide 
useful information, we are confident that the articles 
included in the present scoping review are valuable 
enough to synthesize the most important and current 
knowledge focused on the management of oral hem-
angiomas in pediatric patients. Finally, this scoping 
review only included English language studies. As a 
result, the inherent geographic and cultural diversities 
of the article sample could be limited. Regarding this, 
it has been assumed that most dental researchers, who 
desire to present their results and findings, publish their 
studies in English since it is the internationally accepted 
language to report scientific evidence (47).
Conclusions
As part of the clinical practice, pediatric dentistry prac-
titioners should be familiar with those unusual oral 
tumor-like vascular entities, such as HEMs. These oral-
care specialists should participate in the institution of 
proper early diagnosis and the design of the manage-
ment approach during the multidisciplinary clinical de-
cision-making process. The final aim will be to provide 
optimal therapeutic management and reach adequate 
psychological, functional and esthetic outcomes for the 
affected infant or child, without future complications or 
adverse permanent events.
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